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Abstract
Background: Several studies have determined that dietary intake of B vitamins may be associated with breast cancer
risk as a result of interactions between 5,10-methylenetetrahydrofolate reductase (MTHFR) and methionine synthase (MTR)
in the one-carbon metabolism pathway. However, the association between B vitamin intake and breast cancer risk in
Brazilian women in particular has not yet been investigated.
Methods: A case-control study was conducted in São Paulo, Brazil, with 458 age-matched pairs of Brazilian women.
Energy-adjusted intakes of folate, vitamin B6, and vitamin B12  were derived from a validated Food Frequency
Questionnaire (FFQ). Genotyping was completed for MTHFR A1298C and C677T, and MTR A2756G polymorphisms. A
logistical regression model was used to calculate odds ratios (ORs) and 95% confidence intervals (95% CIs).
Results: Neither dietary intake of folate, vitamin B6, or vitamin B12 nor MTHFR polymorphisms were independently
associated with breast cancer risk. Analysis stratified by menopausal status showed a significant association between
placement in the highest tertile of folate intake and risk of breast cancer in premenopausal women (OR = 2.17, 95% CI:
1.23–3.83; Ptrend = 0.010). The MTR 2756GG genotype was associated with a higher risk of breast cancer than the 2756AA
genotype (OR = 1.99, 95% CI = 1.01–3.92; Ptrend = 0.801), and statistically significant interactions with regard to risk were
observed between the MTHFR A1298C polymorphism and folate (P = 0.024) or vitamin B6 (P = 0.043), and between the
MTHFR C677T polymorphism and folate (P = 0.043) or vitamin B12 (P = 0.022).
Conclusion: MTHFR polymorphisms and dietary intake of folate, vitamin B6, and vitamin B12 had no overall association
with breast cancer risk. However, increased risk was observed in total women with the MTR 2756GG genotype and in
premenopausal women with high folate intake. These findings, as well as significant interactions between MTHFR
polymorphisms and B vitamins, warrant further investigation.
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Background
Folate and other methyl-related B vitamins are essential
nutrients which play important roles in DNA synthesis
(genetics), repair, and methylation (epigenetics). These
roles in turn indicate a potential association for these vita-
mins with the development of several types of cancer [1-
3]. For example, in one folate metabolism pathway, the
enzyme 5,10-methylenetetrahydrofolate reductase (MTHFR)
irreversibly catalyzes the conversion of 5,10-methylene-
tetrahydrofolate (5,10-methylene THF) to 5-methyltet-
rahydrofolate (5-methyl THF), the methyl donor in DNA
methylation. In another, folate leads to purine synthesis
in DNA repair [2-4]. Activity of the MTHFR gene is atten-
uated by two common genetic polymorphisms, the
MTHFR  C677T and A1298C polymorphisms [2,5].
Methionine synthase (MTR), which catalyzes the remethyl-
ation of homocysteine to methionine, has the common
genetic polymorphism MTR A2756G [5,6].
Several studies have suggested an inverse association
between folate intake and breast cancer risk in all women
[7-13], pre- [7,8], and postmenopausal women [7-
9,12,14,15]. However, recent meta-analysis has shown no
clear overall association between folate intake or folate
levels in the blood and breast cancer risk [2,16]. A number
of studies have examined MTHFR  and  MTR  polymor-
phisms [4-6,17-25] and found that variant genotypes of
MTHFR C677T are associated with an increased [4,17,22-
25] or decreased [5,20] risk of breast cancer, while those
of MTHFR A1298C are associated with a decreased risk
[24] and those of MTR A2756G with a decreased risk [6].
Several studies have further reported on the interaction
between these MTHFR  genotypes and folate intake in
affecting risk [4,19]. In addition to the influence of geno-
type, DNA methylation and synthesis are also subject to
the effects of other vitamins relevant to the one-carbon
metabolism pathway, including vitamin B6 (pyridoxine)
as a cofactor of MTHFR and vitamin B12 as a cofactor of
MTR [4,6,19,26]. Although a role for genotype in modify-
ing the association between dietary intake and disease is
biologically plausible [2,4], research into the protective
effects of increasing dietary intake of these B vitamins
against breast cancer risk remains inconclusive [2,27].
In our similar previous case-control study conducted in a
Japanese population, we found no significant association
between dietary folate intake, MTHFR and MTR genotype,
and breast cancer risk [28]. Although the incidence of
breast cancer is higher in Brazilian than Japanese women
[29], the association between B vitamin intake in the diet,
relevant genotypes, and breast cancer risk in Brazilian
populations has not been investigated. Here, we con-
ducted a hospital-based case-control study in São Paulo,
Brazil, to investigate the role of MTHFR and MTR poly-
morphisms in modifying the association of folate and
other B vitamin intake with breast cancer risk in Brazilian
women.
Methods
Subjects
Eligible cases were a consecutive series of female patients
aged 20–74 years with newly diagnosed and histologically
confirmed invasive breast cancer. Cases were recruited
between 2001 and 2006 at eight hospitals in São Paulo
which historically treat a relatively large number of Japa-
nese-Brazilian patients. Eligible controls confirmed not to
have any cancer were selected from the same hospitals,
with one control matched to each case by age (within 5
years) and ethnicity (Caucasian, African, Asian, or mixed)
during the study period. Primary reasons for study
patients visiting a hospital included health check-up
(52%), treatment for gynecological (13%; 64% of which
were uterine myoma), urological (8%), and dermatologi-
cal conditions (6%), clinical examination (8%), and oth-
ers. Of the eligible cases, 472 patients (389 non-Japanese
Brazilian [99%] and 83 Japanese-Brazilian [91%]) gave
written informed consent, while among potential con-
trols, 22 patients refused, resulting in a total of 472
matched pairs ultimately enrolled. The study was
approved by the Comissão Nacional de Ética em Pesquisa
(CONEP), Brasília, Brazil, and by the Institute Review
Board of the National Cancer Center, Tokyo, Japan, in
2000.
Data Collection and Dietary Assessment
In-person interviews were conducted by trained interview-
ers using a structured questionnaire which included ques-
tions on demographic characteristics, medical history,
family history of cancer, anthropometric factors, smoking
habits, physical activities, menstrual and reproductive fac-
tors, as well as a self-quantitative FFQ with 118 food
terms.
The FFQ used here, developed specifically for this study to
estimate dietary intake among participants, inquired
about how often participants consumed individual food
items (frequency of consumption), as well as about repre-
sentative relative sizes compared with standard portions
in the preceding year (control patients) or one year before
their breast cancer diagnosis (cancer patients). Daily food
intake was calculated by multiplying frequency by stand-
ard portion size and relative size for each food item in the
FFQ. Daily intake of nutrients was calculated using the
United States Department of Agriculture (USDA) food
composition tables [30] and the Fifth Revised and
Enlarged Edition of the Standard Tables of Food Compo-
sition in Japan [31] for intake regarding Japanese-specific
foods. The regression-residual model was used to adjust
intake of folate, vitamin B6, and vitamin B12 [32]. Our FFQ
included questions on supplement use, but nutrientBMC Cancer 2009, 9:122 http://www.biomedcentral.com/1471-2407/9/122
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intake data from supplements were not included in anal-
yses, as no comprehensive data for supplements were
available.
The validity of nutrient intake estimated from the FFQ was
evaluated in a subsample of the control group. Fifty-five
women completed a 4-day dietary record (DR) in two sea-
sons. Spearman's correlation coefficient between energy-
adjusted nutrient intakes estimated from the FFQ and DR
was 0.30 for folate, 0.38 for vitamin B6, and 0.33 for vita-
min B12.
Genotype of Polymorphisms
Peripheral blood samples were obtained from each sub-
ject and stored at -80°C until analysis. Genomic DNA
samples were extracted from the blood using QIAGEN
FlexiGene® DNA kits in accordance with the manufac-
turer's protocol. Genotyping of the three single-nucleotide
polymorphisms (SNPs) in the MTHFR and MTR genes
was performed by a commercial laboratory (Genetic Lab.,
Inc., Sapporo, Japan) using TaqMan® SNP Genotyping
Assays developed by Applied Biosystems (Framingham,
MA, USA). Cases and matched controls were analyzed in
the same well by laboratory personnel blinded to case-
control status. To assess quality control, we conducted
laboratory genotyping of six SNPs of four genes (N-acetyl-
transferase 2 [NAT2], cytochrome P450c17α [CYP17], aro-
matase  [CYP19], and cytochrome P450 2E1 [CYP2E1])
using approximately 25% of samples from the present
study, although SNPs used in the present study were not
included. The concordance rates between Genetic Lab.
and our laboratory varied between 97.5% and 99.2% for
the six SNPs.
Data Analysis
Study subjects with markedly low or high total energy
intake (<500 or ≥4000 kcal) or without DNA samples
were excluded from the study, leaving 458 pairs of Brazil-
ian women for analysis (379 non-Japanese Brazilian and
79 Japanese-Brazilian pairs). ORs and 95% CIs for associ-
ations between dietary intake, polymorphisms, and risk of
breast cancer were calculated by the conditional logistical
model, and statistical significance was examined by the
Wald chi-square test. Baseline characteristics between
cases and controls were compared by the Cochran-Man-
tel-Haenszel test using matched-pair strata. Deviation
from the Hardy-Weinberg equilibrium in genotype fre-
quencies was assessed with the chi-square test.
In the primary analysis of all subjects, risk factors identi-
fied by univariate analysis as independently related to dis-
ease risk, including smoking habit, alcohol consumption,
number of live births, and a moderate level of physical
activity in the preceding 5 years, were adjusted in multi-
variable analyses. Other potential confounders such as
age at menarche, age at first live birth, breast feeding,
number of pregnancies, and breast cancer in first-degree
relatives were not independently associated with breast
cancer risk, nor did they substantially modify the effects
when tested in the multivariable model (less than 10%
change in strength), and were thus not retained. Nutrient
intakes of folate, vitamin B6, and vitamin B12 were catego-
rized into tertiles for total study subjects based on the dis-
tribution among controls, with the lowest tertiles
considered as the reference categories.
To increase statistical power, respective genotypes of less-
frequent polymorphisms were also combined into two
groups. Genotypes of MTHFR 677CC and 1298AA, and
MTR 2756AA were considered as the referent group. With
regard to evaluation of the interactive effects of SNPs and
dietary intakes on breast cancer risk, the combined effects
of SNPs and dietary intakes were assessed by adding the
multiplicative interaction product (genotype × dietary
intake) to the final model as indicator variables.
In a secondary analysis, we stratified patients by meno-
pause status, alcohol consumption, and vitamin supple-
ment use using an unconditional logistic model which
adjusted for identified risk factors as well as age and eth-
nicity. Further, trend testing was conducted by treating
each categorized variable as a continuous term and enter-
ing the variable into the logistic regression models. All p
values reported were two-sided, and the significance level
was set at p < 0.05. All analyses were conducted with SAS
9.02 (SAS Institute Inc., Cary, NC, USA).
Results
Characteristics of case and control subjects at baseline are
shown in Table 1. The breast cancer case group tended to
include more smokers and have higher energy intake, but
lower alcohol consumption, less moderate physical activ-
ity, fewer live births, and lower vitamin supplement use
than the control group.
B Vitamins and Breast Cancer Risk
Using the lowest tertile intake of folate, vitamin B6, and
vitamin B12 as reference, no statistically significant associ-
ation was observed between vitamin intake and breast
cancer risk in all women (Table 2). Similar null results
were found in Japanese and non-Japanese women, as well
as in individuals who refrained from alcohol consump-
tion or vitamin supplement use (data not shown). An
increased risk was seen in premenopausal women in the
highest tertile of folate intake (P for trend = 0.010) and in
postmenopausal women in the highest tertile of vitamin
B6 intake (P for trend = 0.047). Similarly, a statistically sig-
nificant increase in risk was seen for high folate intake in
premenopausal women of non-Japanese Brazilian ethnic-
ity (in the highest tertile of folate intake, OR = 1.89, 95%BMC Cancer 2009, 9:122 http://www.biomedcentral.com/1471-2407/9/122
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Table 1: Characteristics of breast cancer and control subjects at baseline in Brazilian women
Cases (n = 458) Controls (n = 458) P*
Mean ± SD†
Age (matching factor), years 53.2 ± 10.9 53.2 ± 10.6 -
Body mass index, kg/m2 26.2 ± 4.7 25.8 ± 4.2 0.207
Age at menarche, years 13.1 ± 1.8 13.1 ± 1.8 0.676
Age at the first live birth, years 24.0 ± 5.5 23.3 ± 5.4 0.082
Age at menopause, years 47.8 ± 6.0 47.6 ± 5.6 0.689
Number (%)
Japanese-Brazilian ethnicity 79 (20.8) 79 (20.8) -
Education to junior college or higher 112 (24.5) 111 (24.3) 0.962
Former and current smoker 183 (40.0) 145 (31.7) 0.009
Occasional and regular alcohol consumption 61 (13.3) 100 (21.8) 0.001
Moderate physical activity in the preceding 5 years 50 (10.9) 79 (17.3) 0.006
≥ 3 Live births 199 (43.5) 238 (52.0) 0.034
Breast cancer in first-degree relative 29 (6.3) 27 (5.9) 0.783
Breast feeding in all women 353 (77.1) 368 (80.4) 0.452
Postmenopausal women 274 (59.8) 289 (63.1) 0.309
Vitamin supplement use 28 (6.1) 54 (11.8) 0.003
Energy-adjusted nutrient intake Mean ± SD†
Folate, μg/day 544.8 ± 160.2 529.4 ± 154.6 0.140
Vitamin B6, mg/day 0.9 ± 0.6 0.9 ± 0.5 0.143
Vitamin B12, μg/day 7.5 ± 8.7 7.0 ± 5.7 0.260
Energy, kcal/day 1815.5 ± 625.4 1722.9 ± 593.6 0.022
†SD, standard deviation.
*Differences between case-control pairs in mean values were tested by the paired t test, and in proportions by the Cochran-Mantel-Haenszel test.
Table 2: Association between energy-adjusted nutrient intake and breast cancer risk in Brazilian women
Total Premenopausal women Postmenopausal women
Nutrient intake* Tertile Case/Control OR† (95% CI)† Case/Control OR‡ (95% CI)‡ Case/Control OR‡ (95% CI)‡
Folate (μg/day) <446.2 140/152 1.00- 4 3 / 6 0 1 . 0 0- 9 7 / 9 2 1 . 0 0-
446.2-<602.2 42/153 1.05 (0.75–1.46) 58/50 1.73 (0.97–3.08) 84/103 0.77 (0.50–1.19)
≥ 602.2 176/153 1.26 (0.89–1.78) 83/59 2.17 (1.23–3.83) 93/94 0.91 (0.59–1.41)
P trend 0.217 0.010 0.685
Vitamin B6 
(mg/day)
<0.6 145/152 1.00 - 63/49 1.00 - 82/103 1.00 -
0.6–<1.0 148/153 1.04 (0.74–1.46) 57/54 0.80 (0.46–1.39) 91/99 1.30 (0.85–1.98)
≥ 1.0 165/153 1.18 (0.84–1.65) 64/66 0.81 (0.48–1.37) 101/87 1.54 (1.01–2.35)
P trend 0.384 0.418 0.047
Vitamin B12 (μg/
day)
<3.9 165/152 1.00 - 61/49 1.00 - 104/103 1.00 -
3.9–<7.3 143/153 0.90 (0.64–1.25) 55/56 0.77 (0.45–1.33) 88/97 0.96 (0.64–1.45)
≥ 7.3 150/153 0.90 (0.65–1.26) 68/64 0.83 (0.49–1.41) 82/89 1.00 (0.65–1.52)
P trend 0.531 0.486 0.949
*Energy-adjusted intakes were categorized among controls by tertiles of folate, vitamin B6, and vitamin B12 for total Brazilian women.
†Adjusted for smoking status (never/ever), alcohol consumption (never/ever), moderate physical activity in the preceding 5 years (no/yes), and 
number of live births (nulliparous/1–2/≥3).
‡Adjusted for age group (20-/30-/40-/50-/60-/≥70), ethnicity (white/mixed/black/yellow), smoking status (never/ever), alcohol consumption (never/
ever), moderate physical activity in the preceding 5 years (no/yes), and number of live births (nulliparous/1–2/≥3).BMC Cancer 2009, 9:122 http://www.biomedcentral.com/1471-2407/9/122
Page 5 of 10
(page number not for citation purposes)
CI = 1.06–3.38; P for trend = 0.037), but not in those of
Japanese-Brazilian ethnicity.
Polymorphisms of MTHFR and MTR Genes and Breast 
Cancer Risk
Associations between polymorphisms of the MTHFR or
MTR genes and breast cancer risk are shown in Table 3. No
deviation from the Hardy-Weinberg equilibrium was
observed in the controls. Compared to the reference
group, women with the MTR 2756GG genotype had a sig-
nificantly increased risk of breast cancer (OR = 1.99, 95%
CI = 1.01–3.92; P for trend = 0.801), but no other statisti-
cally significant associations were observed for all, pre-, or
postmenopausal women. Similar null results were found
in both non-Japanese and Japanese-Brazilian women
(data not shown), although distribution of the MTHFR
C677T polymorphism (CC, CT, and TT genotype) in con-
trol subjects differed significantly between the non-Japa-
nese Brazilian (51%, 39%, and 10%, respectively) and
Japanese-Brazilian women (35%, 52%, and 13%, respec-
tively) (P = 0.038).
We also examined the effects of combined genotypes of
MTHFR A1298C and C677T, MTHFR A1298C and MTR
A2756G, and MTHFR C677T and MTR A2756G, none of
which was statistically significantly associated with the
risk of breast cancer compared to their wild genotypes.
Gene-environment Interactions in Breast Cancer
The joint effects of MTHFR and MTR polymorphisms and
dietary intake on breast cancer risk are shown in Table 4,
in which the genotypes MTHFR 1298AA and 677CC and
MTR  2756AA with the lowest tertiles of dietary intake
were used as references, with variant allele combinations.
Statistically significant positive associations between
folate intake and breast cancer risk were observed among
women with the MTHFR 1298AA (P for trend = 0.003),
677CT and TT (P for trend = 0.011), and MTR 2756AA
genotypes (P for trend = 0.049). An increased risk of
breast cancer was seen in those women with the lowest
folate intake who had the MTHFR 1298AC and CC geno-
type (OR = 1.95, 95% CI = 1.18–3.22). In contrast, a
decreased risk was seen in those women with the lowest
folate intake who had the MTHFR 677CT and TT genotype
(OR = 0.60, 95% CI = 0.37–0.97). Statistically significant
interactions were detected for folate intake with MTHFR
A1298C (P for interaction = 0.024) and C677T polymor-
phisms (P for interaction = 0.043).
A marginally positive association was observed between
the highest tertile of vitamin B6 intake and breast cancer
risk among women with the MTHFR 1298AA genotype (P
for trend = 0.061), whereas an inverse association was
observed between the highest tertile of vitamin B12 intake
and breast cancer risk among those with the MTHFR
677CC genotype (P for trend = 0.073). A statistically sig-
nificant interaction was detected between the MTHFR
A1298C polymorphism and vitamin B6 intake (P for inter-
Table 3: Association between genotype of related enzymes and breast cancer risk in Brazilian women
Gene Allele Total Premenopausal women Postmenopausal women
Case/Control OR† (95% CI)† Case/Control OR‡ (95% CI)‡ Case/Control OR‡ (95% CI)‡
MTHFR_AC AA 269/279 1.00 - 117/107 1.00 - 152/172 1.00 -
AC 168/157 1.11 (0.83–1.50) 63/52 1.09 (0.68–1.75) 105/105 1.11 (0.77–1.58)
CC 21/22 1.03 (0.51–2.10) 4/10 0.39 (0.11–1.35) 17/12 1.96 (0.88–4.37)
P trend 0.543 0.585 0.161
AC+CC 189/179 1.11 (0.83–1.48) 67/62 0.99 (0.63–1.55) 122/117 1.18 (0.84–1.67)
MTHFR_CT CC 225/222 1.00 - 93/86 1.00 - 132/136 1.00 -
CT 188/187 1.02 (0.77–1.36) 75/68 0.98 (0.62–1.56) 113/119 0.96 (0.67–1.38)
TT 45/49 0.88 (0.55–1.42) 16/15 0.88 (0.40–1.95) 29/34 0.78 (0.44–1.38)
P trend 0.743 0.789 0.515
CT+TT 233/236 0.99 (0.76–1.30) 91/83 0.96 (0.62–1.49) 142/153 0.92 (0.65–1.30)
MTR AA 294/294 1.00 - 118/105 1.00 - 176/189 1.00 -
AG 135/149 0.81 (0.59–1.10) 53/56 0.76 (0.47–1.23) 82/93 0.93 (0.64–1.35)
GG 28/15 1.99 (1.01–3.92) 13/8 1.34 (0.51–3.51) 15/7 2.28 (0.88–5.90)
P trend 0.801 0.738 0.543
AG+GG 163/164 0.92 (0.68–1.23) 66/64 0.83 (0.53–1.31) 97/100 1.02 (0.71–1.46)
†Adjusted for smoking status (never/ever), alcohol consumption (never/ever), moderate physical activity in the preceding 5 years (no/yes), and 
number of live births (nulliparous/1–2/≥3).
‡Adjusted for age group (20-/30-/40-/50-/60-/≥70), ethnicity (white/mixed/black/yellow), smoking status (never/ever), alcohol consumption (never/
ever), moderate physical activity in the preceding 5 years (no/yes), and number of live births (nulliparous/1–2/≥3).B
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Table 4: Combined effects of genotype of related enzymes and energy-adjusted nutrient intakes in all breast cancer cases and controls in Brazilian women
Gene Allele Tertile 1 (lower)* Tertile 2 Tertile 3 Ptrend Pinteraction
Case/Control OR† (95%CI)† Case/Control OR (95%CI) Case/Control OR (95%CI)
Folate
MTHFR_AC AA 72/105 1.00 - 87/89 1.40 (0.92–2.14) 110/85 1.76 (1.14–2.72) 0.003 0.024
AC+CC 68/47 1.95 (1.18–3.22) 55/64 1.31 (0.79–2.17) 66/68 1.45 (0.88–2.41) 0.109
MTHFR_CT CC 73/60 1.00 - 62/75 0.72 (0.44–1.17) 90/87 0.84 (0.52–1.37) 0.417 0.043
CT+TT 67/92 0.60 (0.37–0.97) 80/78 0.86 (0.53–1.40) 86/66 1.08 (0.66–1.77) 0.011
MTR AA 86/101 1.00 - 95/102 1.14 (0.75–1.72) 113/91 1.56 (1.01–2.43) 0.049 0.283
AG+GG 54/51 1.21 (0.73–2.00) 46/51 1.12 (0.66–1.90) 63/62 1.07 (0.65–1.77) 0.574
Vitamin B6
MTHFR_AC AA 73/82 1.00 - 85/106 0.99 (0.63–1.55) 111/91 1.50 (0.95–2.37) 0.061 0.043
CA+CC 72/70 1.28 (0.79–2.06) 63/47 1.56 (0.92–2.63) 54/62 1.02 (0.61–1.72) 0.669
MTHFR_CT CC 78/68 1.00 - 68/75 0.80 (0.48–1.33) 79/79 0.90 (0.55–1.48) 0.914 0.273
CT+TT 67/84 0.71 (0.43–1.16) 80/78 0.91 (0.56–1.46) 86/74 1.03 (0.64–1.67) 0.105
MTR AA 91/95 1.00 - 98/100 1.04 (0.67–1.61) 105/99 1.18 (0.77–1.81) 0.435 1.000
AG+GG 54/57 0.92 (0.57–1.50) 50/53 0.95 (0.57–1.59) 59/54 1.07 (0.64–1.79) 0.538
Vitamin B12
MTHFR_AC AA 96/94 1.00 - 76/96 0.78 (0.50–1.20) 97/89 1.10 (0.72–1.68) 0.662 0.088
CA+CC 69/58 1.23 (0.76–2.00) 67/57 1.22 (0.77–1.96) 53/64 0.79 (0.49–1.30) 0.167
MTHFR_CT CC 83/70 1.00 - 79/70 0.90 (0.55–1.47) 63/82 0.59 (0.36–0.97) 0.073 0.022
CT+TT 82/82 0.76 (0.46–1.24) 64/83 0.62 (0.37–1.05) 87/71 1.00 (0.63–1.60) 0.349
MTR AA 105/94 1.00 - 94/105 0.79 (0.52–1.20) 95/95 0.90 (0.59–1.38) 0.560 0.592
AG+GG 60/58 0.81 (0.51–1.31) 48/48 0.92 (0.54–1.57) 55/58 0.76 (0.47–1.23) 0.923
*Energy-adjusted intakes were categorized among controls by tertiles of folate, vitamin B6, and vitamin B12, respectively.
†Adjusted for smoking status (never/ever), alcohol consumption (never/ever), moderate physical activity in the preceding 5 years (no/yes), and number of live births (nulliparous/1–2/≥3).BMC Cancer 2009, 9:122 http://www.biomedcentral.com/1471-2407/9/122
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action = 0.043) and between the MTHFR C677T polymor-
phism and vitamin B12 intake (P for interaction = 0.022).
Discussion
In this study, we found no overall association between
folate, vitamin B6, and vitamin B12 intake and the risk of
breast cancer. These findings are consistent with previous
studies on folate [4,14,16,20,28,33-40], vitamin B6
[4,12,28,35,39,40], and vitamin B12 [8,15,28,39,40].
Generally, folate is able to prevent the development of
tumors before preneoplastic lesions have been estab-
lished, but conversely increases tumorigenesis once
lesions have been established [39,41,42]. Although
increased folate intake may be beneficial in populations
deficient in this nutrient, increased intake in women with
already-sufficient levels of folate may provide no further
benefit, or actually be harmful [34]. Folate intake in Bra-
zilian women in the present study (inter-tertile range,
446.2–602.2 μg/day) was higher than that measured in a
study of Japanese women (inter-tertile range, 386–501
μg/day) [28] and in a meta-analysis of Caucasian and
Asian women (inter-tertile range, 77–255 to 147–359 μg/
day and 132–304 to 206–473 μg/day) [2]. In this study,
we observed an increased risk of breast cancer in premen-
opausal women with high folate intake. Folate levels may
have been already sufficient in the lower intake group,
and thus an increase in intake may on this basis have con-
tributed to tumorigenesis.
Similarly, a study on plasma folate found that concentra-
tion was associated with an increase in breast cancer risk
in premenopausal but not in postmenopausal women
[39]. This study also indicated that the proliferation rate
of breast epithelial cells may be higher in premenopausal
than postmenopausal women, leaving less time for DNA
repair in premenopausal women [39]. Further, a large
population-based case-control study reported that high
dietary vitamin B6 intake was associated with an increased
risk of breast cancer, but did not indicate the menopausal
status of participants [8]. In contrast, another study found
a decreased risk of breast cancer in postmenopausal
women with high plasma levels of vitamin B6 [39]. Our
finding of a significant increase in breast cancer risk in
postmenopausal women due to vitamin B6 intake may
thus be due to chance.
A Canadian study found that a high total folate intake,
obtained mainly from nutritional supplements, signifi-
cantly increased breast cancer risk by 32% (highest >853
μg/day versus lowest quintile ≤336 μg/day) in postmeno-
pausal women [33]. The authors hypothesized that high
folic acid concentrations may contribute to epigenetic
changes in gene-regulatory mechanisms, which may result
in gene silencing and enhanced cancer development, or
may promote the growth of tumors expressing folate
receptors [33,41]. However, the mechanism of this effect
remains unclear [41]. In our study, however, overall vita-
min supplement users (defined as more than once-weekly
use for at least one year) accounted for 11.8% of controls,
and the distribution of supplement users was similar in
the highest and lowest intake groups (data not shown).
Because folate and other B vitamin intake in our popula-
tion was thus obtained primarily from unfortified diets,
the increased risk of breast cancer in premenopausal
women with high folate intake was unlikely due to sup-
plement use.
A recent meta-analysis indicated no overall significant
association between the MTHFR C677T polymorphism
and breast cancer risk in Caucasians and East Asians, or
between the MTHFR A1298C polymorphism and risk in
Caucasians [27]. Our study supports the lack of associa-
tion found in this meta-analysis as well as in others stud-
ies in Caucasian and Asian women [1,5,43]. In contrast to
another finding of the meta-analysis [27], however, which
found an increased risk of breast cancer in premenopausal
women with the MTHFR 677CT and TT genotype com-
pared to those with the CC genotype, we did not observe
any increase in risk in these groups. Further, contrary to
the findings in a previous study conducted in Americans
[1], we did not find an increased risk of breast cancer to be
related to the genotype combination of MTHFR A1298C
and C677T. This lack of concordance in findings may be
due to the low proportion of the MTHFR 677T genotype
in our study population or to compensation by the folate-
replete status of patients for the effects of the variant alle-
les of the MTHFR A1298C and C677T genotypes [2]. Nev-
ertheless, few studies have achieved conclusive results
regarding whether functional polymorphisms in one-car-
bon metabolizing genes affect breast cancer risk associ-
ated with dietary intake of folate and other related B
vitamins, the biological plausibility of this scenario not-
withstanding [2].
The MTR gene contributes to alterations in the plasma lev-
els of homocysteine and folate; specifically, subjects with
the 2756AG and GG genotypes have lower levels of
plasma homocysteine or higher levels of serum folate
than those with the 2756AA genotype [44,45]. When
methionine levels are adequate, these variant polymor-
phisms with lower enzyme activity may also result in ele-
vated homocysteine levels and DNA hypomethylation
[46]. A Polish study reported the possible association
between the hetero- and homozygote variants of the MTR
A2756G and a decreased risk of breast cancer [6]. In the
present study, however, we observed an increased risk of
breast cancer in total subjects who had the MTR 2756GG
genotype, a finding similar to that reported in a recent
study conducted in Taiwan [46]. This observed increaseBMC Cancer 2009, 9:122 http://www.biomedcentral.com/1471-2407/9/122
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may be due to the linkage between the MTR A2756G pol-
ymorphism and other genetic polymorphisms, or to the
interaction between the MTR A2756G polymorphism and
other genetic polymorphisms related to folate metabo-
lism, such as that for methionine synthase reductase
(MTRR G66A) [25,45], cytosolic serine hydroxymethyl-
transferase (cSHMT C1420T) [21], or MTHFR C677T [47].
However, we observed no statistically significant associa-
tions between the combined genotypes of MTR A2756G
and either MTHFR A1298C or C667T and breast cancer
risk, nor could we test the joint effects of MTR with MTRR
or cSHMT genes since MTRR and cSHMT genes were not
available in the present study. Given the low frequency of
the MTR 2756GG genotype in our study population, the
significant finding of our present study may be the result
of chance.
Previous authors have speculated that interactions
between folate and MTHFR polymorphism may be elic-
ited to show that (a) the lower activity of variant geno-
types may increase the risk of breast cancer at low levels of
dietary folate since less 5-methyl THF is made available
for DNA methylation, and (b) variant genotypes might
provide advantages over the wild genotype in folate-
replete conditions since 5,10-methyl THF would be avail-
able for nucleotide synthesis [2,4]. Supporting notion (a),
we found an increased risk of breast cancer among women
with the lowest folate intake who had the MTHFR
1298AC and CC genotype. Contrary to (a), however, we
also saw a decrease in breast cancer risk among women
with the lowest folate intake who had the MTHFR 677CT
and TT genotype. Similar findings of decreased breast can-
cer risk in variant MTHFR C677T genotypes have been
reported in previous studies in German [5], Japanese-
American [20], and Chinese patients [10]. The reduced
activity of the MTHFR C677T polymorphism was specu-
lated to increase the pool of intracellular 5,10-methylene
THF, which protects against potential defects in DNA syn-
thesis, although circulating folate levels (5-methyl THF)
tended to be lower [10]. Nevertheless, the inconsistencies
in results between this and previous studies may be due to
differences in ethnicity [10,19], background dietary status
[19,37], or possibly chance. Given the above discussion
regarding folate intake level, the increased risk of breast
cancer observed here in patients with the MTHFR 1298AA
and MTR 2756AA genotype in a higher tertile of folate
intake may be due to the harmful effects brought about by
excessive intake of folate. Notion (b) suggests that the
lower activity of variant alleles of MTHFR A1298C pro-
vides advantages over the MTHFR 1298AA genotype, but
with the compensation of sufficient folate intake, the
lower enzyme activity was attenuated to result in the lack
of significant association seen with the variant MTHFR
A1298C genotypes in the higher category of folate intake.
In addition, the observed trend to a decline in breast can-
cer risk with increased vitamin B12 intake (P for trend =
0.073) and significant interaction between vitamin B12
and MTHFR C677T polymorphism might be due to the
function of vitamin B12 as a cofactor in folate metabolisms
[12,19].
Several limitations of this study warrant mention. First,
dietary intake of folate, vitamin B6, and vitamin B12 was
assessed after breast cancer diagnosis and was therefore
sensitive to recall bias. Case subjects may have been more
motivated to recall diet than controls, and their recall may
also have been inaccurate, depending on the belief of an
association between diet and their disease. Second,
although substantially high participation rates among
both eligible case and control subjects minimized poten-
tial selection bias, the use of cancer-free patients as con-
trols, whose dietary habits may have differed from the
general population due to health consciousness or disease
concerns, might have lead to selection bias. Third, as our
subjects were recruited from eight hospitals in São Paulo,
Brazil, they may not necessarily be representative of the
general Brazilian population, and thus any extrapolation
of results to the general population should be done cau-
tiously. Fourth, our validation study found relatively low
correlation coefficients between FFQ and DR-based nutri-
ent intake estimates. Further, the validation study indi-
cated that measurement errors in assessing nutrient intake
by FFQ were unavoidable, although such random errors
tend to result in null associations [48]. Fifth, although our
quality control assessment of the genotyping showed high
concordance rates between Genetic Lab. and our labora-
tory, we did not genotype the duplicate blinded samples
of SNPs used in the present study and therefore cannot
rule out the possibility of misclassification in genotyping
status, although its effect on the results might be minimal.
Sixth, stratified analyses were performed based on a rela-
tively small number of cases, possibly limiting the inter-
pretability of our results.
Conclusion
In this case-control study conducted in Brazilian women,
we found no overall significant associations between die-
tary intake of folate, vitamin B6, and vitamin B12, MTHFR
genotype, and breast cancer risk. However, we did identify
an increased risk of breast cancer in total women with the
MTR  2756GG genotype, increased risk associated with
higher folate intake in premenopausal women, and gene-
nutrient interactions. Further studies into these factors
will help to elucidate the etiology of breast cancer.
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